Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Other topical nasal decongestant preparations
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levomenthol 0.3% ointment
120202000AAANAN
|
Generic compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | 90 |
|
Olbas inhaler
120202000BJBDA0
|
Proprietary compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | 8 |
|
Happinose 0.3% ointment
120202000BJBFAN
|
Proprietary compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | 3 |
|
Nostroline 0.3% ointment
120202000BJBAA0
|
Proprietary compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | No data available |
|
Oleum rhinale nasal drops
120202000BJBGA0
|
Proprietary compound preparation BNF 1202020 | Other topical nasal decongestant preparations | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.